Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia

OBJECTIVE To investigate the risk factors for Staphylococcus aureus infective endocarditis (SAIE) and 6-month mortality in patients with S aureus bacteremia (SAB). PATIENTS AND METHODS This study consisted of patients who were diagnosed as having nosocomial or community-acquired SAB or SAIE between...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mayo Clinic proceedings 2007-10, Vol.82 (10), p.1165-1169
Hauptverfasser: Hill, Evelyn E., MD, Vanderschueren, Steven, MD, PhD, Verhaegen, Jan, MD, PhD, Herijgers, Paul, MD, PhD, Claus, Piet, PhD, Herregods, Marie-Christine, MD, PhD, Peetermans, Willy E., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1169
container_issue 10
container_start_page 1165
container_title Mayo Clinic proceedings
container_volume 82
creator Hill, Evelyn E., MD
Vanderschueren, Steven, MD, PhD
Verhaegen, Jan, MD, PhD
Herijgers, Paul, MD, PhD
Claus, Piet, PhD
Herregods, Marie-Christine, MD, PhD
Peetermans, Willy E., MD, PhD
description OBJECTIVE To investigate the risk factors for Staphylococcus aureus infective endocarditis (SAIE) and 6-month mortality in patients with S aureus bacteremia (SAB). PATIENTS AND METHODS This study consisted of patients who were diagnosed as having nosocomial or community-acquired SAB or SAIE between June 1, 2000, and December 31, 2005. Clinical characteristics of patients with SAB were compared with those of patients with SAIE, and predictors of mortality in patients with SAB were analyzed. RESULTS The median age of the 132 randomly selected patients with SAB and the 66 patients with SAIE was 66 and 68 years, respectively. Univariable analysis showed that unknown origin of SAB, a valvular prosthesis, a pacemaker, persistent fever, and persistent bacteremia were significantly associated with SAIE. In multivariable analysis, unknown origin of SAB (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.9-9.3; P =.001), a valvular prosthesis (OR, 9.2; 95% CI, 3.2-26.2; P
doi_str_mv 10.4065/82.10.1165
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68337080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A169826584</galeid><els_id>1_s2_0_S0025619611613888</els_id><sourcerecordid>A169826584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-d229d19df03a5ad7d1d41a3c1d1a62528506f43771b35e72225217ff2c9d51bb3</originalsourceid><addsrcrecordid>eNptkt9rFDEQxxdR7LX64h8gi2AfhDsz2U02-yLU0mqhULGKjyGXTLy0e8mZZAv335v1Dg-L5GGG4TO_8p2qegVk0RLO3gu6KC4AZ0-qGfQtnTPW8qfVjBDK5hx6flQdp3RHCOn6vn1eHUHXE8EonVX41aX7-lLpHGKqbYj1lbeos3vA-sKboFU0LrtUK2_qmzHrsMY62PqLyg59TvUPl1f1bVab1XYIOmg9FnaMWMzHUhUjrp16UT2zakj4cm9Pqu-XF9_OP8-vbz5dnZ9dzzUDmueG0t5AbyxpFFOmM2BaUI0GA4pTRgUj3LZN18GyYdhRWmLQWUt1bxgsl81Jdbqru4nh14gpy7VLGodBeQxjklw0TUcEKeCbR-BdGKMvs0kKXHTAWlGgxQ76qQaUztuQo9LlmbKTDh6tK_Ez4L2gnIn20P5PwgrVkFcpDGN2wad_wXc7UMeQUkQrN9GtVdxKIHLSVAo6uZOmBX69n3VcrtEc0L2IBXi7B1TSarBRee3SgeuhoYxN-7Q7DosEDw6jTLqIqNG4WCSXJrj_9__wKE0PzrvS6R63mP5-HMhEJZG309VNR1eSoRFCNL8BC5DMvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216871548</pqid></control><display><type>article</type><title>Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Hill, Evelyn E., MD ; Vanderschueren, Steven, MD, PhD ; Verhaegen, Jan, MD, PhD ; Herijgers, Paul, MD, PhD ; Claus, Piet, PhD ; Herregods, Marie-Christine, MD, PhD ; Peetermans, Willy E., MD, PhD</creator><creatorcontrib>Hill, Evelyn E., MD ; Vanderschueren, Steven, MD, PhD ; Verhaegen, Jan, MD, PhD ; Herijgers, Paul, MD, PhD ; Claus, Piet, PhD ; Herregods, Marie-Christine, MD, PhD ; Peetermans, Willy E., MD, PhD</creatorcontrib><description>OBJECTIVE To investigate the risk factors for Staphylococcus aureus infective endocarditis (SAIE) and 6-month mortality in patients with S aureus bacteremia (SAB). PATIENTS AND METHODS This study consisted of patients who were diagnosed as having nosocomial or community-acquired SAB or SAIE between June 1, 2000, and December 31, 2005. Clinical characteristics of patients with SAB were compared with those of patients with SAIE, and predictors of mortality in patients with SAB were analyzed. RESULTS The median age of the 132 randomly selected patients with SAB and the 66 patients with SAIE was 66 and 68 years, respectively. Univariable analysis showed that unknown origin of SAB, a valvular prosthesis, a pacemaker, persistent fever, and persistent bacteremia were significantly associated with SAIE. In multivariable analysis, unknown origin of SAB (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.9-9.3; P =.001), a valvular prosthesis (OR, 9.2; 95% CI, 3.2-26.2; P &lt;.001), persistent fever (OR, 3.1; 95% CI, 1.0-9.0; P =.04), and persistent bacteremia (OR, 6.8; 95% CI, 2.3-20.2; P =.001) were independently associated with SAIE. Six-month mortality was 8% in patients with SAB vs 35% in patients with SAIE (OR, 6.5; 95% CI, 2.9-14.8; P &lt;.001). In univariable analysis, methicillin-resistant S aureus (OR, 7.2; 95% CI, 1.7-29.4; P =.005) was significantly associated with 6-month mortality in patients with SAB. CONCLUSION Unknown origin of SAB, a valvular prosthesis, persistent fever, and persistent bacteremia were independently associated with SAIE in patients with SAB. In univariable analysis, methicillin-resistant S aureus was associated with 6-month mortality in patients with SAB. S aureus infective endocarditis had a significantly higher mortality than SAB. The optimal management of SAB and SAIE deserves further study.</description><identifier>ISSN: 0025-6196</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.4065/82.10.1165</identifier><identifier>PMID: 17908522</identifier><identifier>CODEN: MACPAJ</identifier><language>eng</language><publisher>Rochester, MN: Elsevier Inc</publisher><subject>Aged ; Bacteremia - complications ; Biological and medical sciences ; Case-Control Studies ; Complications and side effects ; Endocarditis, Bacterial - etiology ; Epidemiology ; Female ; Fever - complications ; General aspects ; Heart Valve Prosthesis ; Humans ; Infective endocarditis ; Internal Medicine ; Male ; Medical sciences ; Methicillin Resistance ; Middle Aged ; Patient outcomes ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Risk Factors ; Staphylococcal infections ; Staphylococcal Infections - mortality</subject><ispartof>Mayo Clinic proceedings, 2007-10, Vol.82 (10), p.1165-1169</ispartof><rights>Mayo Foundation for Medical Education and Research</rights><rights>2007 Mayo Foundation for Medical Education and Research</rights><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Elsevier, Inc.</rights><rights>Copyright Mayo Foundation for Medical Education and Research Oct 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-d229d19df03a5ad7d1d41a3c1d1a62528506f43771b35e72225217ff2c9d51bb3</citedby><cites>FETCH-LOGICAL-c512t-d229d19df03a5ad7d1d41a3c1d1a62528506f43771b35e72225217ff2c9d51bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19132558$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17908522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hill, Evelyn E., MD</creatorcontrib><creatorcontrib>Vanderschueren, Steven, MD, PhD</creatorcontrib><creatorcontrib>Verhaegen, Jan, MD, PhD</creatorcontrib><creatorcontrib>Herijgers, Paul, MD, PhD</creatorcontrib><creatorcontrib>Claus, Piet, PhD</creatorcontrib><creatorcontrib>Herregods, Marie-Christine, MD, PhD</creatorcontrib><creatorcontrib>Peetermans, Willy E., MD, PhD</creatorcontrib><title>Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>OBJECTIVE To investigate the risk factors for Staphylococcus aureus infective endocarditis (SAIE) and 6-month mortality in patients with S aureus bacteremia (SAB). PATIENTS AND METHODS This study consisted of patients who were diagnosed as having nosocomial or community-acquired SAB or SAIE between June 1, 2000, and December 31, 2005. Clinical characteristics of patients with SAB were compared with those of patients with SAIE, and predictors of mortality in patients with SAB were analyzed. RESULTS The median age of the 132 randomly selected patients with SAB and the 66 patients with SAIE was 66 and 68 years, respectively. Univariable analysis showed that unknown origin of SAB, a valvular prosthesis, a pacemaker, persistent fever, and persistent bacteremia were significantly associated with SAIE. In multivariable analysis, unknown origin of SAB (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.9-9.3; P =.001), a valvular prosthesis (OR, 9.2; 95% CI, 3.2-26.2; P &lt;.001), persistent fever (OR, 3.1; 95% CI, 1.0-9.0; P =.04), and persistent bacteremia (OR, 6.8; 95% CI, 2.3-20.2; P =.001) were independently associated with SAIE. Six-month mortality was 8% in patients with SAB vs 35% in patients with SAIE (OR, 6.5; 95% CI, 2.9-14.8; P &lt;.001). In univariable analysis, methicillin-resistant S aureus (OR, 7.2; 95% CI, 1.7-29.4; P =.005) was significantly associated with 6-month mortality in patients with SAB. CONCLUSION Unknown origin of SAB, a valvular prosthesis, persistent fever, and persistent bacteremia were independently associated with SAIE in patients with SAB. In univariable analysis, methicillin-resistant S aureus was associated with 6-month mortality in patients with SAB. S aureus infective endocarditis had a significantly higher mortality than SAB. The optimal management of SAB and SAIE deserves further study.</description><subject>Aged</subject><subject>Bacteremia - complications</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Complications and side effects</subject><subject>Endocarditis, Bacterial - etiology</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fever - complications</subject><subject>General aspects</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Infective endocarditis</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Middle Aged</subject><subject>Patient outcomes</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Risk Factors</subject><subject>Staphylococcal infections</subject><subject>Staphylococcal Infections - mortality</subject><issn>0025-6196</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNptkt9rFDEQxxdR7LX64h8gi2AfhDsz2U02-yLU0mqhULGKjyGXTLy0e8mZZAv335v1Dg-L5GGG4TO_8p2qegVk0RLO3gu6KC4AZ0-qGfQtnTPW8qfVjBDK5hx6flQdp3RHCOn6vn1eHUHXE8EonVX41aX7-lLpHGKqbYj1lbeos3vA-sKboFU0LrtUK2_qmzHrsMY62PqLyg59TvUPl1f1bVab1XYIOmg9FnaMWMzHUhUjrp16UT2zakj4cm9Pqu-XF9_OP8-vbz5dnZ9dzzUDmueG0t5AbyxpFFOmM2BaUI0GA4pTRgUj3LZN18GyYdhRWmLQWUt1bxgsl81Jdbqru4nh14gpy7VLGodBeQxjklw0TUcEKeCbR-BdGKMvs0kKXHTAWlGgxQ76qQaUztuQo9LlmbKTDh6tK_Ez4L2gnIn20P5PwgrVkFcpDGN2wad_wXc7UMeQUkQrN9GtVdxKIHLSVAo6uZOmBX69n3VcrtEc0L2IBXi7B1TSarBRee3SgeuhoYxN-7Q7DosEDw6jTLqIqNG4WCSXJrj_9__wKE0PzrvS6R63mP5-HMhEJZG309VNR1eSoRFCNL8BC5DMvA</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Hill, Evelyn E., MD</creator><creator>Vanderschueren, Steven, MD, PhD</creator><creator>Verhaegen, Jan, MD, PhD</creator><creator>Herijgers, Paul, MD, PhD</creator><creator>Claus, Piet, PhD</creator><creator>Herregods, Marie-Christine, MD, PhD</creator><creator>Peetermans, Willy E., MD, PhD</creator><general>Elsevier Inc</general><general>Mayo Medical Ventures</general><general>Elsevier, Inc</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20071001</creationdate><title>Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia</title><author>Hill, Evelyn E., MD ; Vanderschueren, Steven, MD, PhD ; Verhaegen, Jan, MD, PhD ; Herijgers, Paul, MD, PhD ; Claus, Piet, PhD ; Herregods, Marie-Christine, MD, PhD ; Peetermans, Willy E., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-d229d19df03a5ad7d1d41a3c1d1a62528506f43771b35e72225217ff2c9d51bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Bacteremia - complications</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Complications and side effects</topic><topic>Endocarditis, Bacterial - etiology</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fever - complications</topic><topic>General aspects</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Infective endocarditis</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Middle Aged</topic><topic>Patient outcomes</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Risk Factors</topic><topic>Staphylococcal infections</topic><topic>Staphylococcal Infections - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hill, Evelyn E., MD</creatorcontrib><creatorcontrib>Vanderschueren, Steven, MD, PhD</creatorcontrib><creatorcontrib>Verhaegen, Jan, MD, PhD</creatorcontrib><creatorcontrib>Herijgers, Paul, MD, PhD</creatorcontrib><creatorcontrib>Claus, Piet, PhD</creatorcontrib><creatorcontrib>Herregods, Marie-Christine, MD, PhD</creatorcontrib><creatorcontrib>Peetermans, Willy E., MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hill, Evelyn E., MD</au><au>Vanderschueren, Steven, MD, PhD</au><au>Verhaegen, Jan, MD, PhD</au><au>Herijgers, Paul, MD, PhD</au><au>Claus, Piet, PhD</au><au>Herregods, Marie-Christine, MD, PhD</au><au>Peetermans, Willy E., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>82</volume><issue>10</issue><spage>1165</spage><epage>1169</epage><pages>1165-1169</pages><issn>0025-6196</issn><eissn>1942-5546</eissn><coden>MACPAJ</coden><abstract>OBJECTIVE To investigate the risk factors for Staphylococcus aureus infective endocarditis (SAIE) and 6-month mortality in patients with S aureus bacteremia (SAB). PATIENTS AND METHODS This study consisted of patients who were diagnosed as having nosocomial or community-acquired SAB or SAIE between June 1, 2000, and December 31, 2005. Clinical characteristics of patients with SAB were compared with those of patients with SAIE, and predictors of mortality in patients with SAB were analyzed. RESULTS The median age of the 132 randomly selected patients with SAB and the 66 patients with SAIE was 66 and 68 years, respectively. Univariable analysis showed that unknown origin of SAB, a valvular prosthesis, a pacemaker, persistent fever, and persistent bacteremia were significantly associated with SAIE. In multivariable analysis, unknown origin of SAB (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.9-9.3; P =.001), a valvular prosthesis (OR, 9.2; 95% CI, 3.2-26.2; P &lt;.001), persistent fever (OR, 3.1; 95% CI, 1.0-9.0; P =.04), and persistent bacteremia (OR, 6.8; 95% CI, 2.3-20.2; P =.001) were independently associated with SAIE. Six-month mortality was 8% in patients with SAB vs 35% in patients with SAIE (OR, 6.5; 95% CI, 2.9-14.8; P &lt;.001). In univariable analysis, methicillin-resistant S aureus (OR, 7.2; 95% CI, 1.7-29.4; P =.005) was significantly associated with 6-month mortality in patients with SAB. CONCLUSION Unknown origin of SAB, a valvular prosthesis, persistent fever, and persistent bacteremia were independently associated with SAIE in patients with SAB. In univariable analysis, methicillin-resistant S aureus was associated with 6-month mortality in patients with SAB. S aureus infective endocarditis had a significantly higher mortality than SAB. The optimal management of SAB and SAIE deserves further study.</abstract><cop>Rochester, MN</cop><pub>Elsevier Inc</pub><pmid>17908522</pmid><doi>10.4065/82.10.1165</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0025-6196
ispartof Mayo Clinic proceedings, 2007-10, Vol.82 (10), p.1165-1169
issn 0025-6196
1942-5546
language eng
recordid cdi_proquest_miscellaneous_68337080
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Bacteremia - complications
Biological and medical sciences
Case-Control Studies
Complications and side effects
Endocarditis, Bacterial - etiology
Epidemiology
Female
Fever - complications
General aspects
Heart Valve Prosthesis
Humans
Infective endocarditis
Internal Medicine
Male
Medical sciences
Methicillin Resistance
Middle Aged
Patient outcomes
Public health. Hygiene
Public health. Hygiene-occupational medicine
Risk Factors
Staphylococcal infections
Staphylococcal Infections - mortality
title Risk Factors for Infective Endocarditis and Outcome of Patients With Staphylococcus aureus Bacteremia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A52%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Factors%20for%20Infective%20Endocarditis%20and%20Outcome%20of%20Patients%20With%20Staphylococcus%20aureus%20Bacteremia&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Hill,%20Evelyn%20E.,%20MD&rft.date=2007-10-01&rft.volume=82&rft.issue=10&rft.spage=1165&rft.epage=1169&rft.pages=1165-1169&rft.issn=0025-6196&rft.eissn=1942-5546&rft.coden=MACPAJ&rft_id=info:doi/10.4065/82.10.1165&rft_dat=%3Cgale_proqu%3EA169826584%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216871548&rft_id=info:pmid/17908522&rft_galeid=A169826584&rft_els_id=1_s2_0_S0025619611613888&rfr_iscdi=true